Your search - Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation - did not match any documents. Suggestions: Make sure all words are spelled correctly. Try different keywords.